About this Research Topic
In the realm of infectious diseases, Lyme borreliosis and other tick-borne diseases represent a significant and growing public health challenge worldwide. The spectrum of pathogens transmitted by ticks includes bacteria and parasites, which are typically treatable with antimicrobials, and viruses, which require mostly supportive care. Despite the availability of vaccines against tick-borne encephalitis, the development of a vaccine for Lyme borreliosis is still in the final stages of clinical trials. The need for comprehensive research and development is underscored by the varying efficacy of current interventions and the complex clinical presentations of these infections.
This research topic aims to deepen understanding and enhance the management of Lyme borreliosis and other tick-borne diseases by focusing on multidisciplinary strategies that address prevention, diagnosis, and treatment. The goal is to improve patient outcomes by identifying the best practices for managing persistent infections, refining diagnostic tools, and developing therapeutic approaches that can mitigate the long-term consequences of these diseases.
To gather further insights in the management of tick-borne diseases, we welcome articles addressing, but not limited to, the following themes:
- Pathogenesis of persistent Lyme borreliosis infection.
- Evaluating treatment modalities for persistent Lyme borreliosis post-standard treatment.
- Optimal management strategies for diverse manifestations of Lyme disease, including neurological impacts.
- Clinical trials evaluating the safety and efficacy of new vaccines and treatment modalities.
- Real-world data on the effectiveness and safety of vaccinations and antibiotic treatments.
- Comparative studies on the epidemiology of Lyme borreliosis and its various clinical outcomes.
- Cost-effectiveness of treatments and vaccines from multiple healthcare perspectives.
This research topic aims to deepen understanding and enhance the management of Lyme borreliosis and other tick-borne diseases by focusing on multidisciplinary strategies that address prevention, diagnosis, and treatment. The goal is to improve patient outcomes by identifying the best practices for managing persistent infections, refining diagnostic tools, and developing therapeutic approaches that can mitigate the long-term consequences of these diseases.
To gather further insights in the management of tick-borne diseases, we welcome articles addressing, but not limited to, the following themes:
- Pathogenesis of persistent Lyme borreliosis infection.
- Evaluating treatment modalities for persistent Lyme borreliosis post-standard treatment.
- Optimal management strategies for diverse manifestations of Lyme disease, including neurological impacts.
- Clinical trials evaluating the safety and efficacy of new vaccines and treatment modalities.
- Real-world data on the effectiveness and safety of vaccinations and antibiotic treatments.
- Comparative studies on the epidemiology of Lyme borreliosis and its various clinical outcomes.
- Cost-effectiveness of treatments and vaccines from multiple healthcare perspectives.
Keywords: Lyme borreliosis, tick-borne disease, Borrelia burgdorferi, persistent infection, pathogenesis, vaccine
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
